IRTC iRhythm Technologies
- 108.985
- -2.755-2.47%
iRhythm Technologies News
What Makes IRhythm Technologies (IRTC) a Lucrative Investment?
IRhythm Technologies to Report First Quarter 2024 Financial Results on May 2, 2024
SAN FRANCISCO, April 18, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today
Needham Sees BSX, CNMD, RMD Beating Street, Despite Medtech Slow Down
Insiders At IRhythm Technologies Sold US$7.6m In Stock, Alluding To Potential Weakness
Over the past year, many iRhythm Technologies, Inc. (NASDAQ:IRTC) insiders sold a significant stake in the company which may have piqued investors' interest. Knowing whether insiders are buying is u
IRhythm Technologies (IRTC) Surges 4.2%: Is This an Indication of Further Gains?
Loss-Making IRhythm Technologies, Inc. (NASDAQ:IRTC) Expected To Breakeven In The Medium-Term
IRhythm Technologies, Inc. (NASDAQ:IRTC): When Will It Breakeven?
We feel now is a pretty good time to analyse iRhythm Technologies, Inc.'s (NASDAQ:IRTC) business as it appears the company may be on the cusp of a considerable accomplishment. iRhythm Technologies,
Analysts Are Bullish on These Healthcare Stocks: MacroGenics (MGNX), Irhythm Technologies (IRTC)
IRhythm Technologies Closes $661 Million Notes Offering
iRhythm Technologies (IRTC) said Friday it closed the private placement of 1.50% convertible senior notes due 2029 for gross proceeds of $661.3 million. The proceeds include fully exercised overallotm
Press Release: IRhythm Announces Closing of $661.25 Million of 1.50% Convertible Senior Notes Due 2029, Including Full Exercise of Initial Purchasers' $86.25 Million Option to Purchase Additional Notes
iRhythm Announces Closing of $661.25 Million of 1.50% Convertible Senior Notes Due 2029, Including Full Exercise of Initial Purchasers' $86.25 Million Option to Purchase Additional Notes SAN FRANCISC
Insider Sell: EVP, CMO & CSO Minang Turakhia Sells 943 Shares of IRhythm Technologies Inc (IRTC)
Irhythm Technologies Insider Sold Shares Worth $360,983, According to a Recent SEC Filing
Mark J. Day, Chief Technology Officer, on March 04, 2024, sold 3,248 shares in Irhythm Technologies (IRTC) for $360,983. Following the Form 4 filing with the SEC, Day has control over a total of 61,16
Convertible-Bond Sales Are Booming. MicroStrategy, SoFi, Albemarle Plan Deals.
Attractive financing rates and a strong stock market are pushing chief financial officers to issue more convertible bonds.
Analysts' Top Healthcare Picks: Avidity Biosciences (RNA), Irhythm Technologies (IRTC)
IRhythm Upsizes Convertible Notes Offering to $575 Million
iRhythm Technologies, Inc. (NASDAQ: IRTC), a digital healthcare company, has upsized its private placement offering to $575 million in convertible senior notes due in 2029, an increase from the initially announced $450 million.
IRhythm Prices Upsized Offering of $575.0 Million of 1.50% Convertible Senior Notes Due 2029
SAN FRANCISCO, March 04, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. ("iRhythm") (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict and help prevent
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
Express News | IRhythm Technologies Shares Are Trading Lower After the Company Announced a $450 Million Proposed Offering of Convertible Senior Notes
Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday
U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday. Shares of Tesla, Inc. (NASDAQ:TSLA) fell during Monday's session after the company reportedly saw a decline in Fe
Express News | IRhythm Announces Proposed Offering Of $450M Of Convertible Senior Notes
Analysis
Price Target
No Data
